[unable to retrieve full-text content] Predictors of antiretroviral treatment failure to the first line therapy: a cross-sectional study among Iranian HIV-positive adults BMC Infectious Diseases
[unable to retrieve full-text content] New report documents increase in HIV drug resistance to dolutegravir World Health Organization (WHO)
[unable to retrieve full-text content] Persistent sore throat could be a sign of STI; 5 other uncommon symptoms you should know The Indian Express
[unable to retrieve full-text content] U.S. clinical trials begin for twice-yearly HIV prevention injection National Institutes of Health (NIH) (.gov)
[unable to retrieve full-text content] Diagnostics company Binx Health banks $65M to drive growth of point-of-care testing Fierce healthcare
[unable to retrieve full-text content] Gilead to Present Late-Breaking Data Highlighting Antiviral Portfolio, Innovative Research Pipeline and HIV Leadership at IDWeek 2024 StockTitan
[unable to retrieve full-text content] WHO updates guidelines to enhance access to HIV post-exposure prophylaxis World Health Organization (WHO)
[unable to retrieve full-text content] Fact-checking Aaron Rodgers, who repeated Robert F. Kennedy Jr.'s false claims about HIV/AIDS Poynter
[unable to retrieve full-text content] Patients with HIV-Associated Lymphoma Can Safely Continue Anti-Retroviral Therapy During Chemotherapy Fox Chase Cancer Center
[unable to retrieve full-text content] Recommendations for the treatment of Trichomonas vaginalis, Mycoplasma genitalium, Candida albicans, bacterial vaginosis and human papillomavirus (anogenital warts) World Health Organization (WHO)
[unable to retrieve full-text content] Hispanic women are less likely to get PrEP treatment − new intervention could change that The Conversation Indonesia